510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2260-2018Class II

The BD Vacutainer Plus Plastic Citrate Blood Collection Tube is an evacuated blood collection tube that...

Becton Dickinson & Co / initiated 2018-04-11 / Terminated / root cause: manufacturing process

Becton Dickinson & Company began a recall of The BD Vacutainer Plus Plastic Citrate Blood Collection Tube is an evacuated blood collection tube that provides a means of collecting, transporting, and... on . FDA classified it as Class II and gives the reason as "Approximately 3.4% of BD Vacutainer Plus Plastic Citrate Blood Collection Tubes (2.7mL) (light blue top tube) will exhibit over fill draw volumes from ~11-14%". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2260-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Becton Dickinson & Co
Product
The BD Vacutainer Plus Plastic Citrate Blood Collection Tube is an evacuated blood collection tube that provides a means of collecting, transporting, and processing blood in a closed tube. The buffered sodium citrate additive provides an anticoagulated specimen that may be used for clinical laboratory coagulation assays.
Product code
JKA Tubes, Vials, Systems, Serum Separators, Blood Collection
Reason for recall
Approximately 3.4% of BD Vacutainer Plus Plastic Citrate Blood Collection Tubes (2.7mL) (light blue top tube) will exhibit over fill draw volumes from ~11-14%.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
BD began notifying distributors on April 11, 2018. Customer communications were mailed on April 12-13th, 2018. US customers will be sent a letter via UPS beginning April 12, 2018. Distributors were e-mailed on April 11, 2018 and requested that they provide a list of their consignees to facilitate mailing to end users BD Regions will be contacted via email regarding distribution outside of the US Distributors were instructed to return customer lists to BD. Letters will be mailed with UPS tracking, which provides for a 100% effectiveness check. Customer response form will be tabulated. 100% of non-responders will be contacted by phone.
Distribution
US/PR-All 50 states and PR Global-AR, BO, BR, BS, BZ, CA, CO, CR, CW, DO, EC, GT, GY, IN, JM, JP, KR, MX, NI, PA, PE, SG, SR, SV, TT, TW, UY, VI Dates of distribution: June 2, 2017 to the present.
Product codes and lots
All lots

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2260-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2258-2018Class IITerminatedVoluntary: Firm initiated
Z-2259-2018Class IITerminatedVoluntary: Firm initiated
Z-2260-2018Class IITerminatedVoluntary: Firm initiated